PhnyX Lab
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PhnyX Lab - overview
Established
2024
Location
Palo Alto, CA, US
Primary Industry
Software
About
Founded in 2024 and based in California, US, PhnyX Lab is a software development company that provides data integration and automation tools for the pharmaceutical industry. In August 2025, PhnyX Lab raised USD 4 million in seed funding led by SK Networks, with participation from individual investors. PhnyX Lab is an AI startup that is focused on transforming pharmaceutical research and healthcare workflows. The company specializes in intelligent document automation and generative AI tools that simplify complex tasks like literature reviews, clinical trial analysis, and regulatory documentation.
The company plans to use the 2025 funding to expand its team, enhance its data automation platform, and develop new tools for pharmaceutical documentation.
Current Investors
SK Networks
Primary Industry
Software
Sub Industries
Pharmaceuticals, Application Integration Software, Medical Software
Verticals
Artificial Intelligence, Cloud Computing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.